Primary: adverse events ‐ any adverse event treatment‐related (application site pruritus) · participants with moderate to severe hand eczema
Corticosteroid creams/ointments: clobetasol propionate foam showed no clear difference in primary: adverse events ‐ any adverse event treatment‐related… compared with vehicle foam (moderate certainty).
1 finding from 1 review
Secondary: reduction in severity, participant‐rated scoring · participants with moderate to severe hand eczema
Corticosteroid creams/ointments: clobetasol propionate foam probably leads to higher secondary: reduction in severity, participant‐rated scoring compared with vehicle foam (moderate certainty).
1 finding from 1 review
Secondary: reduction in severity, investigator‐rated scoring ‐ improvement at least 2 grades · participants with moderate to severe hand eczema
Corticosteroid creams/ointments: clobetasol propionate foam showed no clear difference in secondary: reduction in severity, investigator‐rated scoring ‐… compared with vehicle foam (moderate certainty).
1 finding from 1 review
Participant‐reported pain relief of 30% or greater · adults with moderate or severe pain associated with postherpetic neuralgia
1 finding from 1 review
Patient Global Impression of Change much or very much improved · adults with moderate or severe pain associated with postherpetic neuralgia
1 finding from 1 review
no estimate extracted
Studies not reported
Very low
Lack of efficacy withdrawal · adults with moderate or severe pain associated with postherpetic neuralgia
1 finding from 1 review
Somnolence · adults with moderate or severe pain associated with postherpetic neuralgia
1 finding from 1 review
Dizziness · adults with moderate or severe pain associated with postherpetic neuralgia
1 finding from 1 review
Withdrawals due to adverse events · adults with moderate or severe pain associated with postherpetic neuralgia
1 finding from 1 review
Participant‐reported pain relief of 30% or greater · adults with moderate or severe pain associated with painful diabetic neuropathy
1 finding from 1 review
Participant‐reported pain relief of 50% or greater · adults with moderate or severe pain associated with painful diabetic neuropathy
1 finding from 1 review
Patient Global Impression of Change much or very much improved · adults with moderate or severe pain associated with painful diabetic neuropathy
1 finding from 1 review
PGIC very much improved · adults with moderate or severe pain associated with painful diabetic neuropathy
1 finding from 1 review
Lack of efficacy withdrawal · adults with moderate or severe pain associated with painful diabetic neuropathy
1 finding from 1 review
Participant‐reported pain relief of 50% or greater · adults with moderate or severe pain associated with postherpetic neuralgia
1 finding from 1 review
Somnolence · adults with moderate or severe pain associated with painful diabetic neuropathy
1 finding from 1 review
Dizziness · adults with moderate or severe pain associated with painful diabetic neuropathy
1 finding from 1 review
Withdrawals due to adverse events · adults with moderate or severe pain associated with painful diabetic neuropathy
1 finding from 1 review
Participant‐reported pain relief of 30% or greater · adults with moderate or severe pain associated with painful diabetic neuropathy
1 finding from 1 review
Participant‐reported pain relief of 50% or greater · adults with moderate or severe pain associated with painful diabetic neuropathy
1 finding from 1 review